“Cost-Effectiveness of Pioglitazone in Patients With Type 2 Diabetes and a History of Macrovascular Disease in a Swiss Setting”. Swiss Medical Weekly, vol. 139, no. 1112, Mar. 2009, pp. 173-, https://doi.org/10.4414/smw.2009.12381.